In Sickle Cell Project, Baylor Scientist Discovers Link to Fetal Hemoglobin Production with Ingenuity Variant Analysis from QIAGEN

Just two decades ago, there were virtually no therapeutic treatments for patients with sickle cell anemia, a severe condition in which blood cells form rigid sickle shapes, damaging several organs in the body. Today, there’s not only a medication, but thanks to new research from Vivien Sheehan and data interpretation from QIAGEN’s Ingenuity Variant Analysis, scientists also have a promising new lead for another treatment option.